Expanding horizons in iron chelation and the treatment of cancer: Role of iron in the regulation of ER stress and the epithelial–mesenchymal transition
- 1 April 2014
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1845 (2) , 166-181
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council of Australia (NHMRC)
- NHMRC
- Cancer Institute New South Wales
- NHMRC Project Grant (1048972)
This publication has 178 references indexed in Scilit:
- N‐myc downstream regulated gene 1 modulates Wnt‐β‐catenin signalling and pleiotropically suppresses metastasisEMBO Molecular Medicine, 2012
- A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium StudyCancer Chemotherapy and Pharmacology, 2011
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Snail Family Regulation and Epithelial Mesenchymal Transitions in Breast Cancer ProgressionJournal of Mammary Gland Biology and Neoplasia, 2010
- Population pharmacokinetics of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (Triapine®) in cancer patientsCancer Chemotherapy and Pharmacology, 2010
- The maximum tolerated dose and biologic effects of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) in combination with irinotecan for patients with refractory solid tumorsCancer Chemotherapy and Pharmacology, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Wnt/β-Catenin Signaling: Components, Mechanisms, and DiseasesDevelopmental Cell, 2009
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- The Hallmarks of CancerCell, 2000